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Epidemiology is occurrence research.1 The object of 
epidemiologic research is the occurrence of illness 
and its relation to determinants (occurrence relation). 
Similar to other epidemiologic research, the motive 
for applied clinical studies is to learn about an object. 
Eventually, the knowledge produced by the research 
needs to be incorporated in the knowledge base that 
guides daily medical care. During the design and 
conduct of research, it is important to keep this aim 
in mind and be aware of the effects that choices in the 
design of the study may have on the applicability and 
implementation of the results.  
In the critical theoretical, initial phase of study 
design, the occurrence relation is laid out with all of 
its elements. Following the theoretical design, a plan is 
made of how to obtain and summarize knowledge on 
the nature and strength of the occurrence relation from 
available or induced experience, e.g., from empirical 
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data collected in groups of subjects. Here, a number 
of decisions need to be taken, apart from the actual 
way data are being collected. To be able to move from 
theoretical design to data collection, the occurrence 
relation needs to re-phrased in both theoretical and 
operational terms. This will not only point the way 
to measurement techniques in data collection but 
also indicate compromises that need to be made to 
match the ideal format of information on outcome 
and determinants to what can practically be achieved. 
For example, suppose we wish to precisely quantify 
the relation between presence of heart failure and 
subsequent loss of patient autonomy and quality of 
life. In the data collection, we may then have to settle 
for dyspnea to classify heart failure and the Euroqol 
questionnaire to assess quality of life.2 This need not 
be a problem, but it is important that these choices 
are made explicit and recognized in the interpretation 
of the research. Both the measure of the outcome and 
the determinant are mere proxies for what we really 
aim to evaluate. In applied clinical research, it is 
commonly important to stay close to what matters to 
patients when deciding upon measures of outcome of 
diseases. This is not necessarily intuitive to all clinical 
investigators. 
Not infrequently, investigators rely most on what 
can be quantified in solid measures rather than on 
what has the biggest impact for a patient. We reviewed 
studies on new positive inotropic drugs in heart 
failure.3 The profound impact that congestive heart 
failure has on life expectancy and quality of life has 
been a continuous stimulus for the development of 
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new drugs for the treatment of this condition. Despite 
favorable effects on (aspects of ) quality of life in short-
term studies, several new agents have been shown to 
reduce survival in mortality trials. However, patients 
with severe congestive heart failure may experience 
such incapacitating symptoms that the question should 
be raised as to whether an improvement in quality of 
life makes the increased risk of mortality associated 
with these new agents acceptable. Drugs that improve 
quality of life at the expense of an increased risk of 
mortality can be of value in the treatment of patients 
with severe congestive heart failure. However, this is 
only the case if the probability of improvement in 
quality of life and prolongation of life expectancy 
for those using the drug exceeds the probability of 
improvement in quality of life and prolongation of life 
expectancy for those not using the drug. Unfortunately, 
most clinical trials in which both mortality and quality 
of life are evaluated fail to provide information on 
this composite probability. In clinical research there 
is a justified growing emphasis on measures of disease 
that matter to patients, the importance of which 
was underlined by the outcomes movement and 
summarized in a seminal publication in the New 
England Journal of Medicine in 1988.4
Questions that trigger applied clinical research 
result from problems and lack of knowledge perceived 
in patient care. Certain questions are relevant for certain 
groups of patients and not to others. Consequently, 
research findings may be relevant to smaller or larger 
groups of patients. The essence of scientific research, 
in contrast to other forms of systematic gathering of 
data, is that its results can be generalized. The type 
of knowledge provided by clinical epidemiologic 
research is inferential, probabilistic knowledge. This 
knowledge contrasts with factual knowledge because 
it is not time- and place-specific. It is true for any 
patient or groups of patients as long as the findings, 
on which the knowledge is based, permit scientific 
generalization to those patients. The patient is a special 
case of a category of patients to whom the occurrence 
relation applies. In the initial theoretical phase of study 
design, a careful appreciation of the type of patients for 
which the research needs to be relevant is important. 
The (theoretical) population of patients to which the 
findings apply is called the domain of the study. The 
domain description can be viewed as a pharmaceutical 
package insert of a study: “please use for this type of 
patient”. In the choice of a population for empirical 
data collection (= the study population), the domain 
should be kept in mind. 
Members of the study population should represent 
the (virtual) population of the domain. Apart from 
criteria for selection of a study population that follow 
from the chosen domain, such as the severity of 
disease or a certain indication for diagnostic work-
up, other restrictions may be necessary in recruiting 
participants in a study that result from logistic or other 
circumstances. Many of these additional restrictions, 
such as the need to live close to the research center 
and availability of time for additional diagnostic 
assessments, will not have an impact on the eventual 
applicability of the results and therefore will not in turn 
limit the domain. It is important to appreciate which 
characteristics of a study population are determined 
with a view to the intended domain and as such form 
part of the design, and which characteristics result from 
reasons beyond the theoretical design. 
With a view to the study domain, those charac-
teristics of the study population need particular 
consideration that bear on the generalizability of the 
empirical relation. The generalizability of research 
results, sometimes referred to as the external validity is 
the extent to which knowledge obtained in a particular 
type of patient may be generalized to another larger, 
theoretical, abstract group of patients. Suppose that a 
study is conducted to determine the value of a certain 
novel type of surgery in patients with a particular 
gastrointestinal disease. The results of the study could 
be that recovery in operated patients of type T is more 
common than in non-operated ones, conditional on 
all extraneous determinants (confounders) of recovery. 
The conclusion is that operation enhances recovery in 
patients of type T, without reference to time or place. 
The results are generalized from the group of patients 
in which the empirical data were collected to a larger 
group of theoretical patients representing the domain 
of the research. 
Generalizability is not an objective process that can 
easily be framed in statistical terms. Moving from time- 
and place-specific findings to scientific knowledge 
requires judgement about the potential of other 
characteristics inherent to the research setting and 
study population to modify the nature and strength 
of the relation between determinant(s) and outcomes 
as estimated in the study. 
Appreciation of generalizability is essential for 
scientific inference. Definition of the domain of a 
study as part of the occurrence relation is important 
because the domain of a relation provides the basis 
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for generalization. As a rule, the utility of research is 
greater if the domain of the research findings, e.g., 
the generalizability of the estimated relations between 
outcome and determinants, is broader. Consequently, 
while the design of the occurrence relation needs to 
be precise and comprehensive, the domain is generally 
implicitly or explicitly kept broad. In diagnostic 
research, the domain is defined by the loosely defined 
patient profile representing those subjects for which a 
particular diagnostic question is relevant. In etiologic 
research the domain is formed by people at risk for the 
illness at issue and with variability of the causal factor 
at issue. For example, the domain for research on the 
etiological role of smoking in lung cancer are all human 
beings with lungs and the possibility to smoke. In 
prognostic research, again, the domain is defined by the 
patient profile of those for whom prognostic statements 
based on the determinants included in the research are 
considered. In research into effects of treatments the 
domain is those who may need treatment. 
Where most elements of scientific research require 
maximal specificity, the domain is, in general, loosely 
defined. Apart from smaller or larger restrictions in 
the empirical data of a study, either by design or by 
circumstances, differences will persist to exist among 
those using the results of research with respect to 
their willingness to generalize to larger groups. For 
example, in the absence of results from randomized 
trials specifically demonstrating the clinical benefits 
of use of statins in women with elevated cholesterol 
levels, some people did not accept an indication for use 
of these drugs in women in spite of ample evidence of 
reductions of risk in men with similar risk profiles.
As a final point, it has increasingly been acknowled-
ged that the principles and methods of epidemiology 
may be fruitfully employed in applied clinical research. 
In parallel with a growing emphasis in medicine to use 
quantitative evidence to guide patient care and to judge 
its performance, epidemiology has become one of the 
fundamental disciplines for patient-oriented research 
and a cornerstone for evidence-based medicine. To 
serve clinical practice best, research should be relevant, 
valid, and precise. Consequently, research results 
can eventually be applied with confidence in daily 
practice.
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The essence of knowledge is generalization. That fire can be produced by rubbing wood a certain way is a 
knowledge derived from individual experiences; the statement means that  rubbing wood in this way will always 
produce fire. The art of discovery is therefore the art of generalization. What is irrelevant, such as the particular 
shape or size of the piece of wood used is to be excluded from the generalization: what is relevant, for example, 
the dryness of the wood, is to be included in it.  The meaning of the term relevant can thus be defined: that is 
relevant which must be mentioned for the generalization to be valid. The separation of relevant from irrelevant 
factors is the beginning of knowledge. 
Reichenbach H in: The rise of scientific philosophy. New York: Harper and Row. 1965 (Quoted in Rothman, Modern 
Epidemiology)5
